This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.93% per year. These returns cover a period from January 1, 1988 through October 6, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
rsi: Archive
Down 10.3% in 4 Weeks, Here's Why You Should You Buy the Dip in Boston Scientific (BSX)
by Zacks Equity Research
Boston Scientific (BSX) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
BSXNegative Net Change
rsi stock-price-movement
After Plunging 10.4% in 4 Weeks, Here's Why the Trend Might Reverse for Hamilton Lane (HLNE)
by Zacks Equity Research
Hamilton Lane (HLNE) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
HLNEPositive Net Change
rsi stock-price-movement
Here's Why Corteva, Inc. (CTVA) is Poised for a Turnaround After Losing 15% in 4 Weeks
by Zacks Equity Research
Corteva, Inc. (CTVA) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
CTVAPositive Net Change
rsi stock-price-movement
After Plunging 9.1% in 4 Weeks, Here's Why the Trend Might Reverse for DocuSign (DOCU)
by Zacks Equity Research
DocuSign (DOCU) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
DOCUNegative Net Change
rsi stock-price-movement
Down 10% in 4 Weeks, Here's Why OneMain (OMF) Looks Ripe for a Turnaround
by Zacks Equity Research
The heavy selling pressure might have exhausted for OneMain (OMF) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
OMFPositive Net Change
rsi stock-price-movement
Down 21.9% in 4 Weeks, Here's Why Stitch Fix (SFIX) Looks Ripe for a Turnaround
by Zacks Equity Research
Stitch Fix (SFIX) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
SFIXPositive Net Change
rsi stock-price-movement
Down 13.7% in 4 Weeks, Here's Why You Should You Buy the Dip in Deckers (DECK)
by Zacks Equity Research
Deckers (DECK) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
DECKNegative Net Change
rsi stock-price-movement
Rigel (RIGL) Loses 27.0% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
Rigel (RIGL) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
RIGLNegative Net Change
rsi stock-price-movement
Nasdaq (NDAQ) Loses 5.4% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
Nasdaq (NDAQ) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
NDAQPositive Net Change
rsi stock-price-movement
The Oncology Institute (TOI) Loses 20% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
The Oncology Institute (TOI) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
TOIPositive Net Change
rsi stock-price-movement
After Plunging 34.6% in 4 Weeks, Here's Why the Trend Might Reverse for LivePerson (LPSN)
by Zacks Equity Research
LivePerson (LPSN) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
LPSNNegative Net Change
rsi stock-price-movement
Sprouts Farmers (SFM) Loses 14.8% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
Sprouts Farmers (SFM) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
SFMPositive Net Change
rsi stock-price-movement
Down 19.8% in 4 Weeks, Here's Why Groupon (GRPN) Looks Ripe for a Turnaround
by Zacks Equity Research
Groupon (GRPN) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
GRPNPositive Net Change
rsi stock-price-movement
Down 29.3% in 4 Weeks, Here's Why FiscalNote Holdings, Inc. (NOTE) Looks Ripe for a Turnaround
by Zacks Equity Research
FiscalNote Holdings, Inc. (NOTE) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
NOTENegative Net Change
rsi stock-price-movement
Here's Why Sagimet Biosciences Inc. (SGMT) is Poised for a Turnaround After Losing 15.8% in 4 Weeks
by Zacks Equity Research
The heavy selling pressure might have exhausted for Sagimet Biosciences Inc. (SGMT) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
SGMTNegative Net Change
rsi stock-price-movement
Down 10.3% in 4 Weeks, Here's Why Cheesecake Factory (CAKE) Looks Ripe for a Turnaround
by Zacks Equity Research
The heavy selling pressure might have exhausted for Cheesecake Factory (CAKE) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
CAKENegative Net Change
rsi stock-price-movement
Down 11.9% in 4 Weeks, Here's Why Skillsoft (SKIL) Looks Ripe for a Turnaround
by Zacks Equity Research
Skillsoft (SKIL) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
SKILNegative Net Change
rsi stock-price-movement
Soleno Therapeutics (SLNO) Loses 26% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
Soleno Therapeutics (SLNO) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
SLNONegative Net Change
rsi stock-price-movement
After Plunging 8.9% in 4 Weeks, Here's Why the Trend Might Reverse for PSEG (PEG)
by Zacks Equity Research
The heavy selling pressure might have exhausted for PSEG (PEG) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
PEGPositive Net Change
rsi stock-price-movement
Down 25.9% in 4 Weeks, Here's Why ELUTIA INC (ELUT) Looks Ripe for a Turnaround
by Zacks Equity Research
ELUTIA INC (ELUT) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
ELUTPositive Net Change
rsi stock-price-movement
INmune Bio (INMB) Loses 23.8% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
INmune Bio (INMB) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
INMBNegative Net Change
rsi stock-price-movement
Array Digital (AD) Loses 29.2% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
The heavy selling pressure might have exhausted for Array Digital (AD) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
ADPositive Net Change
rsi stock-price-movement
Here's Why Alight (ALIT) is Poised for a Turnaround After Losing 24.4% in 4 Weeks
by Zacks Equity Research
The heavy selling pressure might have exhausted for Alight (ALIT) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
ALITNegative Net Change
rsi stock-price-movement
After Plunging 14.8% in 4 Weeks, Here's Why the Trend Might Reverse for Torrid Holdings (CURV)
by Zacks Equity Research
Torrid Holdings (CURV) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
CURVNegative Net Change
rsi stock-price-movement
Down 8.8% in 4 Weeks, Here's Why You Should You Buy the Dip in Sprouts Farmers (SFM)
by Zacks Equity Research
The heavy selling pressure might have exhausted for Sprouts Farmers (SFM) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
SFMPositive Net Change
rsi stock-price-movement